Hospital care costs are out of control. Price caps can help.
By Andy Ryan and Roslyn Murray of Brown University
While we race to fight the coronavirus, there’s a brewing storm on the horizon for our healthcare supply chains.
Disciplines:
BusinessEugene Schneller is a Professor of Supply Chain Management at the W. P. Carey School of Business at Arizona State University. His research and consulting focus on health sector supply chain strategy, group purchasing, distribution models, and talent development. He has studied public and private health care procurement in both the U.S. and abroad with a focus on design, integrity, efficiency, and effectiveness. His recent clients include the Children's Hospital Association, HCA, CombineMed, FTI, Health Industry Group Purchasing Association, and Costal Carolinas Health Alliance. Prior to ASU, Dr. Schneller's academic appointments were in very diverse settings, including business, liberal arts, medicine, and public health. He has held positions in the Mel and Enid Zuckerman College of Public Health, University of Arizona, University of Colorado, Union College, Albany Medical College, Columbia University, and Duke University. He is on the editorial review board for several academic journals and serves on the Board of Directors for the Health Administrators Forum, the Network for Health Administration Education, and the Arizona Governor's Council on Telemedicine. Dr. Schneller has a Ph.D. in sociology from New York University.
By Eugene Schneller, Arizona State University
Each day, the headlines remind us of the desperate shortage of medical supplies to fight the coronavirus. Healthcare workers are forced to treat patients without proper protective gear, manufacturers are scrambling to produce ventilators and masks, and rumors about unproven treatments lead to runs on drug supplies.
While healthcare, policy, and business leaders race to address these urgent needs, there’s a brewing storm on the horizon for our healthcare system that we must not ignore. People’s everyday medical concerns didn’t disappear with the coronavirus, and they can’t be put on hold indefinitely. At the same time, supply chains throughout the world have been disrupted as factories remain shuttered or shift their production to coronavirus supplies.
Fighting the coronavirus pandemic must be our first priority, but we also need to anticipate broader destabilizations in the healthcare supply chain that will ripple out in the coming months, as supplies are exhausted and manufacturers struggle to meet heightened demand. If we don’t turn our attention to these cascading problems, we may wake up and find ourselves unable to fill prescriptions for chronic conditions or secure surgical supplies to treat accident victims or usher newborns into the world. We must act now to head off a healthcare supply shortage that could be even broader and deeper than the one we’re currently facing…
Read the full article at Fast Company.
This article was produced by Footnote in partnership with W.P. Carey School of Business.
Get in touch about this workA secure, centralized workspace where faculty upload notes, papers, and lecture materials—and instantly receive clear, accurate, publication-ready drafts across formats: op-eds, research briefs, executive summaries, pitches, public commentary, and more.
Discover More